iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference taking place September 10th, 2026 in New York.
Event: Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference
Who: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James
Date: Thursday, September 10, 2026
Location: Metropolitan Club, New York City
Format: One-on-one meetings
Investors wishing to meet with IMDX management are encouraged to reach out to their Lake Street sales representative.
About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.
GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.
Investor Contact:
Alexandra Grossman
LifeSci Advisors LLC
imdx@lifesciadvisors.com
© Copyright Globe Newswire, Inc. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Globe Newswire, Inc.
